NCT06905197
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06905197
Title A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)
Acronym TIAN-SHAN1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dizal Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health RECRUITING New York New York 10016 United States Details
Herbert Irving Comprehensive Cancer Center RECRUITING New York New York 10032 United States Details
Virginia Cancer Specialist (NEXT Oncology-Virginia) ACTIVE_NOT_RECRUITING Fairfax Virginia 22031 United States Details
Blacktown Hospital ACTIVE_NOT_RECRUITING Blacktown New South Wales 2148 Australia Details
Chris O'Brien Lifehouse NOT_YET_RECRUITING Camperdown New South Wales 2050 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field